• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童尤文肉瘤新辅助化疗完全缓解后刮除、苯酚和骨水泥治疗。

Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.

机构信息

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Int Orthop. 2019 Feb;43(2):467-473. doi: 10.1007/s00264-018-4094-5. Epub 2018 Aug 11.

DOI:10.1007/s00264-018-4094-5
PMID:30099643
Abstract

PURPOSE

Although wide resection is the standard treatment for Ewing's sarcoma (ES), it has complications especially in children. In this study, we compared the oncologic and functional outcomes of wide resection with extended curettage and local adjuvant therapy (phenolization and cementation), as a less extensive surgery for paediatric ES with a complete radiologic response to neoadjuvant chemotherapy.

METHODS

Children aged ≤ ten years, with ES of non-expendable long-bones and complete radiologic response to neoadjuvant chemotherapy, were included in this case-control study. Twenty-six patients were treated with extended curettage and local adjuvant therapy (case group) and 17 were managed with wide resection (control group). The average follow-up period was 60.1 ± 28.7 months (range 30-168 months). Functional outcome was assessed with the Musculoskeletal Tumor Society (MSTS) scoring system.

RESULTS

Three local recurrences (11.5%) and three distant metastases (11.5%) were observed in the case group. Two local recurrences (11.7%) and two metastases (11.7%) were recorded in the control group. The rate of local recurrence was not statistically different between the two study groups (p = 0.668). The rate of metastasis was not statistically different between the two study groups as well (p = 0.668). The complication rates were 15% in the case group and 53% in the control group (p = 0.005). The mean MSTS score was 98.3% and 74% in the case and control group, respectively (p < 0.001).

CONCLUSION

The oncologic outcome of extended curettage and local adjuvant therapy in paediatric ES with complete radiological response to neoadjuvant chemotherapy is comparable to wide resection, yet it offers considerably better functional results.

摘要

目的

尽管广泛切除术是尤文肉瘤(Ewing's sarcoma,ES)的标准治疗方法,但它存在许多并发症,尤其是在儿童中。在本研究中,我们比较了广泛切除术和扩大刮除术联合局部辅助治疗(苯酚化和骨水泥)在完全缓解新辅助化疗的儿童尤文肉瘤中的肿瘤学和功能结果,后者是一种较为广泛的手术。

方法

本病例对照研究纳入了年龄≤10 岁、非可扩张长骨尤文肉瘤且对新辅助化疗完全缓解的儿童患者。26 例患者接受了扩大刮除术和局部辅助治疗(病例组),17 例患者接受了广泛切除术(对照组)。平均随访时间为 60.1±28.7 个月(范围 30-168 个月)。功能结果采用肌肉骨骼肿瘤学会(Musculoskeletal Tumor Society,MSTS)评分系统进行评估。

结果

病例组中有 3 例(11.5%)局部复发和 3 例(11.5%)远处转移,对照组中有 2 例(11.7%)局部复发和 2 例(11.7%)远处转移。两组的局部复发率无统计学差异(p=0.668)。两组的转移率也无统计学差异(p=0.668)。病例组的并发症发生率为 15%,对照组为 53%(p=0.005)。病例组和对照组的 MSTS 评分分别为 98.3%和 74%(p<0.001)。

结论

对于完全缓解新辅助化疗的儿童尤文肉瘤,扩大刮除术联合局部辅助治疗的肿瘤学结果与广泛切除术相当,但功能结果要好得多。

相似文献

1
Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.儿童尤文肉瘤新辅助化疗完全缓解后刮除、苯酚和骨水泥治疗。
Int Orthop. 2019 Feb;43(2):467-473. doi: 10.1007/s00264-018-4094-5. Epub 2018 Aug 11.
2
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.在骨肉瘤新辅助化疗维持阶段的标准四联方案中添加异环磷酰胺和依托泊苷并无优势:两项序贯研究的结果
J Chemother. 1993 Aug;5(4):247-57. doi: 10.1080/1120009x.1993.11739240.
3
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.异环磷酰胺联合依托泊苷用于新诊断的骨尤文肉瘤
J Clin Oncol. 1992 Nov;10(11):1737-42. doi: 10.1200/JCO.1992.10.11.1737.
4
Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.成人高危骨尤文肉瘤的长期多药化疗
Med Oncol. 2009;26(3):276-86. doi: 10.1007/s12032-008-9115-6. Epub 2008 Nov 7.
5
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.骨肉瘤新辅助化疗:在维持阶段将异环磷酰胺和依托泊苷添加到长春新碱、放线菌素、环磷酰胺和阿霉素方案中未观察到益处——两项序贯研究的结果
Cancer. 1998 Mar 15;82(6):1174-83. doi: 10.1002/(sici)1097-0142(19980315)82:6<1174::aid-cncr24>3.0.co;2-2.
6
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.在诱导期将异环磷酰胺和放线菌素-D添加到长春新碱、环磷酰胺和多柔比星中,可改善肢体非转移性尤因肉瘤患者的组织学反应和预后。
J Chemother. 1998 Dec;10(6):484-91. doi: 10.1179/joc.1998.10.6.484.
7
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.一项关于尤因肉瘤放射治疗的多学科研究:儿童肿瘤学组POG #8346的最终结果。
Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35. doi: 10.1016/s0360-3016(98)00191-6.
8
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.尤因肉瘤的放射治疗:CESS 86试验的最新情况
Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30. doi: 10.1016/0360-3016(95)00016-r.
9
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.骨肉外周恶性神经外胚层肿瘤的新辅助化疗:里佐利研究所的近期经验
J Clin Oncol. 2000 Feb;18(4):885-92. doi: 10.1200/JCO.2000.18.4.885.
10
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.接受辅助化疗的非转移性骨尤文肉瘤的预后因素:里佐利骨科研究所359例患者的分析
J Clin Oncol. 2000 Jan;18(1):4-11. doi: 10.1200/JCO.2000.18.1.4.

引用本文的文献

1
Outcomes of Megaprosthesis ‎Reconstruction for the Salvage of ‎Failed Osteoarticular Allograft ‎‎Around the Knee implanted before ‎Skeletal Maturity in Primary Bone ‎Sarcoma: A Case-Series.原发性骨肉瘤骨骼成熟前植入的膝关节周围失败的骨关节同种异体移植挽救性大假体重建的结果:病例系列
Arch Bone Jt Surg. 2024;12(3):211-218. doi: 10.22038/ABJS.2023.74212.3434.
2
Establishment of Iran Musculoskeletal Tumor Registry: A Study Protocol and Lessons Learned from Implementation and the Pilot Phase.伊朗肌肉骨骼肿瘤登记处的建立:一项研究方案以及实施和试点阶段的经验教训
Med J Islam Repub Iran. 2023 Apr 12;37:37. doi: 10.47176/mjiri.37.37. eCollection 2023.
3

本文引用的文献

1
Long-term Results of Osteoarticular Allograft Reconstruction in Children with Distal Femoral Bone Tumors.儿童股骨远端骨肿瘤同种异体骨关节移植重建的长期结果
Arch Bone Jt Surg. 2017 Sep;5(5):296-301.
2
Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients.儿童盆腔肉瘤的外科治疗:26例患者的治疗结果
Int Orthop. 2017 Oct;41(10):2149-2159. doi: 10.1007/s00264-017-3564-5. Epub 2017 Jul 27.
3
A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors.尤因肉瘤家族性肿瘤的儿科患者与成人患者的比较
Total Synovectomy and Bone Grafting/Cementation after Curettage of the Bone Lesion in Diffuse‏ Type ‏of Tenosynovial‏ Giant Cell Tumor‎: A Retrospective Cohort Study.
弥漫型腱鞘巨细胞瘤骨病变刮除术后全滑膜切除术及植骨/骨水泥填充:一项回顾性队列研究
Arch Bone Jt Surg. 2023;11(5):342-347. doi: 10.22038/ABJS.2023.67493.3203.
4
Non-spinal Hydatid Disease of Bone: A Series of Nine Cases.骨非脊柱包虫病:9例病例系列
Arch Bone Jt Surg. 2022 May;10(5):447-452. doi: 10.22038/ABJS.2021.54448.2717.
5
How the Choice of Osteosynthesis Affects the Complication Rate of Intercalary Allograft Reconstruction? A Systematic Review and Meta-analysis.骨内固定的选择如何影响节段性同种异体骨重建的并发症发生率?一项系统评价和荟萃分析。
Indian J Orthop. 2021 Nov 10;56(4):547-558. doi: 10.1007/s43465-021-00563-7. eCollection 2022 Apr.
6
Bioinformatics Analysis of ZBTB16 as a Prognostic Marker for Ewing's Sarcoma.ZBTB16 作为尤文肉瘤预后标志物的生物信息学分析。
Biomed Res Int. 2021 Oct 6;2021:1989917. doi: 10.1155/2021/1989917. eCollection 2021.
7
Management of the Cavity After Removal of Giant Cell Tumor of the Bone.骨巨细胞瘤切除术后骨腔的处理
Front Surg. 2021 Jul 29;8:626272. doi: 10.3389/fsurg.2021.626272. eCollection 2021.
8
Early Diagnosis of Giant Solitary Synovial Chondromatosis of the Hip Using Ultrasound-guided Synovial Biopsy: A Case Report.超声引导下滑膜活检对髋关节巨大孤立性滑膜软骨瘤病的早期诊断:一例报告
Arch Bone Jt Surg. 2021 Mar;9(2):235-239. doi: 10.22038/abjs.2020.43730.2200.
9
Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study.刮除术加植骨与整块切除术治疗病理性膝关节 3 级巨细胞瘤:一项回顾性研究。
Int Orthop. 2021 Jan;45(1):289-297. doi: 10.1007/s00264-020-04836-y. Epub 2020 Oct 1.
Front Oncol. 2017 May 8;7:82. doi: 10.3389/fonc.2017.00082. eCollection 2017.
4
Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.尤因肉瘤:只有化疗后坏死率达100%的患者才应被归类为反应良好。
Bone Joint J. 2016 Aug;98-B(8):1138-44. doi: 10.1302/0301-620X.98B8.37346.
5
EWING'S SARCOMA: EPIDEMIOLOGY AND PROGNOSIS FOR PATIENTS TREATED AT THE PEDIATRIC ONCOLOGY INSTITUTE, IOP-GRAACC-UNIFESP.尤因肉瘤:在儿科肿瘤研究所(IOP-GRAACC-UNIFESP)接受治疗的患者的流行病学与预后
Rev Bras Ortop. 2015 Dec 8;47(4):446-50. doi: 10.1016/S2255-4971(15)30126-9. eCollection 2012 Jul-Aug.
6
Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.尤因肉瘤化疗反应的三维放射学评估可用于预测临床结果。
Radiology. 2016 Sep;280(3):905-15. doi: 10.1148/radiol.2016151301. Epub 2016 Mar 16.
7
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.尤因肉瘤:通过合作实现的当前管理和未来方法。
J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24.
8
Diagnosis and treatment of Ewing sarcoma of the bone: a review article.骨尤因肉瘤的诊断与治疗:一篇综述文章。
J Orthop Sci. 2015 Mar;20(2):250-63. doi: 10.1007/s00776-014-0687-z. Epub 2015 Feb 19.
9
Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of giant cell tumours.苯酚对骨巨细胞瘤辅助治疗的细胞毒性作用及组织穿透性
Oncol Lett. 2013 May;5(5):1595-1598. doi: 10.3892/ol.2013.1244. Epub 2013 Mar 11.
10
Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells.辐照通过破坏骨髓微环境来诱导骨损伤。
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1609-14. doi: 10.1073/pnas.1015350108. Epub 2011 Jan 10.